Qiang Lü
Direttore/Membro del Consiglio presso GOODY SCIENCE AND TECHNOLOGY CO., LTD.
Posizioni attive di Qiang Lü
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| GOODY SCIENCE AND TECHNOLOGY CO., LTD. | Direttore/Membro del Consiglio | 28/12/2020 | - |
Genfleet Therapeutics (Shanghai), Inc.
 Genfleet Therapeutics (Shanghai), Inc. Miscellaneous Commercial ServicesCommercial Services Genfleet Therapeutics (Shanghai), Inc. is a Chinese clinical-stage biotechnology company that focuses on developing novel drug candidates for unmet medical needs in oncology and immunology. The company is based in Shanghai, China, and was founded in 2017 by Jiong Lan and Qiang Lü. The company has built up industry-leading capabilities and expertise in developing both small molecules and biologics since its inception in 2017. Genfleet's proprietary and fully integrated R&D platform highlights multiple cutting-edge products with novel mechanisms and IP. The company's pipeline includes over 10 programs, many of which have entered multi-regional clinical trials across China. Genfleet has completed co-development partnerships with a number of publicly listed companies worldwide. Jiong Lan has been the CEO since 2017. | Presidente | 22/08/2017 | - |
| Fondatore | 22/08/2017 | - |
Storia della carriera di Qiang Lü
Statistiche
Distribuzione geografica
| Cina | 3 |
Posizioni
| Director/Board Member | 1 |
| Chairman | 1 |
| Founder | 1 |
Settori
| Producer Manufacturing | 2 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| GOODY SCIENCE AND TECHNOLOGY CO., LTD. | Producer Manufacturing |
| Aziende private | 1 |
|---|---|
Genfleet Therapeutics (Shanghai), Inc.
Genfleet Therapeutics (Shanghai), Inc. Miscellaneous Commercial ServicesCommercial Services Genfleet Therapeutics (Shanghai), Inc. is a Chinese clinical-stage biotechnology company that focuses on developing novel drug candidates for unmet medical needs in oncology and immunology. The company is based in Shanghai, China, and was founded in 2017 by Jiong Lan and Qiang Lü. The company has built up industry-leading capabilities and expertise in developing both small molecules and biologics since its inception in 2017. Genfleet's proprietary and fully integrated R&D platform highlights multiple cutting-edge products with novel mechanisms and IP. The company's pipeline includes over 10 programs, many of which have entered multi-regional clinical trials across China. Genfleet has completed co-development partnerships with a number of publicly listed companies worldwide. Jiong Lan has been the CEO since 2017. | Commercial Services |
- Borsa valori
- Insiders
- Qiang Lü
- Esperienza
